Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
199
-
Total 13F shares, excl. options
-
55.7M
-
Shares change
-
+1.34M
-
Total reported value, excl. options
-
$4.29B
-
Value change
-
+$92.8M
-
Put/Call ratio
-
0.65
-
Number of buys
-
88
-
Number of sells
-
-101
-
Price
-
$77.12
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q3 2018
246 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q3 2018.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 199 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.7M shares
of 58.6M outstanding shares and own 94.93% of the company stock.
Largest 10 shareholders include FMR LLC (8.7M shares), WELLINGTON MANAGEMENT GROUP LLP (7.87M shares), Vanguard Group Inc (4.25M shares), BlackRock Inc. (3.29M shares), Capital International Investors (3.1M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.83M shares), BB BIOTECH AG (2.2M shares), STATE STREET CORP (1.56M shares), Clearbridge Investments, LLC (1.51M shares), and Woodford Investment Management Ltd (1.32M shares).
This table shows the top 199 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.